Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 78

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 3
Chunk 78
---
...  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  we may not be able to maintain the confidentiality of our trade secrets or other proprietary information;  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────

  we may not develop or in-license additional proprietary technologies that are patentable; and  
 ─────────────────────────────────────────────────────────────────────────────────────────────────

  the patents of others may have an adverse effect on our business.  
 ─────────────────────────────────────────────────────────────────────

Should any of these events
occur, they could materially harm our business and the results of our operation.

Risks Related to Our Operations, Employee Matters
and Managing Growth

We are highly dependent on our key personnel,
and if we are not successful in attracting and retaining highly qualified personnel, we may not be able to successfully implement our
business strategy.

Our ability to compete in
the highly competitive biotechnology, medical device and pharmaceutical industries depends upon our ability to attract and retain highly
qualified managerial, scientific and medical personnel. We are highly dependent on our management, scientific and medical personnel, including
Uzi Sofer, our Chief Executive Officer. The loss of the services of any of our executive officers, other key employees and other scientific
and medical advisors, and an inability to find suitable replacements, could result in delays in product development and harm our business.

We conduct the majority of
our operations at our facility in Israel. The region is headquarters to many other biopharmaceutical and medical device companies and
many academic and research institutions. Competition for skilled personnel in the healthcare market is intense and may limit our ability
to hire and retain highly qualified personnel on acceptable terms or at all. Changes to Israeli or similar immigration and work authorization
laws and regulations, including those that restrain the flow of scientific and professional talent, can be significantly affected by political
forces and levels of economic activity. Our business may be materially adversely affected if legislative or administrative changes to
Israeli or similar foreign immigration or visa laws and regulations impair our hiring processes and goals or projects involving personnel
who are not Israeli citizens.

To encourage valuable employees
to remain at our company, in addition to salary and cash incentives, we have provided stock options that vest over time. The value to
employees of stock options that vest over time may be significantly affected by movements in our share price that are beyond our control,
and may at